Hiroyuki Shimada

Q: What Schools Are Affiliated With Hiroyuki Shimada

Hiroyuki Shimada is affiliated with the following schools: University of Tokyo, Kyoto Prefectural University, University of Southern California, Vanderbilt University, Stanford University, California South Bay University, Institute of Science Tokyo, University of California, San Francisco, Kyoto University

Hiroyuki Shimada's AcademicInfluence.com Rankings

Hiroyuki Shimada

Computer Science

#9703

World Rank

#10180

Historical Rank

Computational Linguistics

#2379

World Rank

#2402

Historical Rank

Machine Learning

#4318

World Rank

#4367

Historical Rank

Artificial Intelligence

#4671

World Rank

#4733

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Hiroyuki Shimada's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Hiroyuki Shimada Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hiroyuki Shimada's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. (1999) (1639)
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. (2010) (1385)
The International Neuroblastoma Pathology Classification (the Shimada system) (1999) (913)
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. (2009) (741)
Terminology and morphologic criteria of neuroblastic tumors (1999) (610)
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification‐an intergroup rhabdomyosarcoma study (1995) (500)
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. (2005) (483)
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. (1992) (467)
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. (1999) (363)
Chromosome 1p and 11q deletions and outcome in neuroblastoma. (2005) (299)
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. (2015) (291)
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors (2001) (273)
Preferential Susceptibility of Brain Tumors to the Antiangiogenic Effects of an &agr;v Integrin Antagonist (2001) (270)
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. (2009) (258)
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. (2010) (239)
The International Neuroblastoma Pathology Classification. (2003) (239)
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. (2000) (225)
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. (2000) (225)
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. (2006) (224)
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. (2012) (223)
Revision of the International Neuroblastoma Pathology Classification (2003) (222)
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. (2000) (221)
Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment (2004) (221)
αv‐Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin (2002) (219)
Computer-aided prognosis of neuroblastoma on whole-slide images: Classification of stromal development (2009) (213)
Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines. (2010) (208)
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. (1998) (207)
Molecular differential pathology of rhabdomyosarcoma (1989) (207)
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. (2001) (199)
E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. (2007) (177)
PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts (2010) (176)
EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. (2005) (174)
Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. (2001) (167)
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. (2009) (164)
Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. (1998) (159)
Computer-aided evaluation of neuroblastoma on whole-slide histology images: Classifying grade of neuroblastic differentiation (2009) (156)
Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. (1991) (155)
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. (1995) (152)
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. (2005) (151)
Bone sarcomas as second malignant neoplasms following childhood cancer (1991) (151)
Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. (1996) (150)
Pediatric Tumor Cells Express Erythropoietin and a Functional Erythropoietin Receptor that Promotes Angiogenesis and Tumor Cell Survival (2003) (139)
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. (2010) (136)
Integrins αvβ3 and αvβ5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide (2000) (136)
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. (2005) (134)
BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. (2008) (130)
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors (2001) (124)
Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. (2005) (119)
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. (2013) (118)
Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. (1991) (113)
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study (2015) (105)
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. (2008) (105)
Effects of Methylenetetrahydrofolate Reductase and Reduced Folate Carrier 1 Polymorphisms on High-Dose Methotrexate-Induced Toxicities in Children With Acute Lymphoblastic Leukemia or Lymphoma (2006) (105)
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells. (2017) (104)
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. (2013) (103)
Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. (2000) (103)
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial. (2016) (102)
Image Analysis for Neuroblastoma Classification: Segmentation of Cell Nuclei (2006) (100)
Entry and Intracellular Replication of Escherichia coli K1 in Macrophages Require Expression of Outer Membrane Protein A (2003) (100)
Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia. (2011) (100)
The Matrix Metalloproteinase Inhibitor Prinomastat Enhances Photodynamic Therapy Responsiveness in a Mouse Tumor Model (2004) (95)
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group (2017) (93)
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. (2001) (91)
Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications (1994) (90)
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641. (2012) (89)
Human and mouse tissue-engineered small intestine both demonstrate digestive and absorptive function. (2015) (84)
Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. (1993) (84)
Malignant rhabdoid tumor. A study with two established cell lines (1993) (84)
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group (2021) (81)
Outer membrane protein A expression in Enterobacter sakazakii is required to induce microtubule condensation in human brain microvascular endothelial cells for invasion. (2008) (79)
Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. (2005) (77)
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors (2002) (72)
A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma. (2012) (72)
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis. (2002) (70)
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium (2013) (69)
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG (2009) (68)
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study. (2015) (67)
Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984–1999 (2010) (66)
Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial (2012) (66)
Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial (2012) (65)
Computer-aided Prognosis of Neuroblastoma: Detection of mitosis and karyorrhexis cells in digitized histological images (2009) (65)
Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group (2017) (64)
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma (2021) (63)
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group (2013) (62)
Pathology of fatal rhabdomyosarcoma. Report from intergroup rhabdomyosarcoma study (IRS‐I and IRS‐II) (1987) (62)
Identification of Galectin-3-binding Protein as a Factor Secreted by Tumor Cells That Stimulates Interleukin-6 Expression in the Bone Marrow Stroma* (2008) (61)
Influence of MTHFR and RFC1 Polymorphisms on Toxicities During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia or Lymphoma (2008) (61)
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2 (2007) (60)
Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan (2016) (58)
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. (2000) (57)
Mechanisms of bone invasion and metastasis in human neuroblastoma. (2005) (57)
Endothelial apoptosis induced by inhibition of integrins αvβ3 and αvβ5 involves ceramide metabolic pathways (2005) (57)
Morphologic features of neuroblastoma (Schwannian stroma‐poor tumors) in clinically favorable and unfavorable groups (2002) (57)
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age. (2006) (56)
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma (2015) (55)
Undifferentiated (Embryonal) Sarcoma of the Liver A Tumor of Uncertain Histogenesis Showing Divergent Differentiation (1991) (55)
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database. (2016) (54)
Matrix Metalloproteinases and Their Inhibitors in Tumor Progression a (1994) (52)
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High‐Risk Neuroblastoma (2016) (52)
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma (2018) (50)
Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23). (1991) (50)
Pleuropulmonary Blastoma in Childhood: A Tumor of Divergent Differentiation (1993) (50)
Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein. (1998) (49)
Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate. (2003) (49)
Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas (2013) (48)
Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia. (1999) (47)
A significant association of Ha‐ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases (1991) (47)
Platelet-Derived Growth Factor Receptor β Is Critical for Zebrafish Intersegmental Vessel Formation (2010) (47)
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. (2014) (46)
The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis. (1999) (45)
Biological aspects of neuroblastomas identified by mass screening in Quebec. (2001) (45)
Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis (1992) (45)
Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype (2013) (45)
Position‐specific expression of Hox genes along the gastrointestinal tract (2004) (44)
Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells (2017) (44)
Screening for neuroblastoma in North America. 2-year results from the Quebec Project. (1992) (43)
The role of surgery in localized neuroblastoma. (1985) (43)
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age (2010) (42)
Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia (2018) (42)
One hundred neuroblastomas detected through a mass screening system in Japan (1994) (41)
Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis (2002) (41)
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular (2000) (41)
Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group (TCCSG) Study L04-16 (2018) (40)
Secondary malignant neoplasms after high‐dose chemotherapy and autologous stem cell rescue for high‐risk neuroblastoma (2014) (40)
Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature (2012) (39)
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC (2017) (38)
Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development (2003) (38)
IMAGE ANALYSIS FOR AUTOMATED ASSESSMENT OF GRADE OF NEUROBLASTIC DIFFERENTIATION (2007) (37)
Citrobacter koseri Brain Abscess in the Neonatal Rat: Survival and Replication within Human and Rat Macrophages (2003) (36)
Large cell neuroblastoma (2004) (36)
Generation of the NUP98–HOXD13 fusion transcript by a rare translocation, t(2;11)(q31;p15), in a case of infant leukaemia (2000) (35)
Implantable chemotherapy‐loaded silk protein materials for neuroblastoma treatment (2017) (35)
First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability (2004) (35)
Malignant lymphoma of the liver (1992) (34)
Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study (2006) (34)
Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children's Oncology Group (2014) (34)
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells (2019) (34)
Validation of a prognostic multi‐gene signature in high‐risk neuroblastoma using the high throughput digital NanoString nCounter™ system (2014) (34)
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531. (2019) (33)
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program. (2010) (33)
Uterine Cervical Dysplasia and Cancer: Identification of C-myc Status by Quantitative Polymerase Chain Reaction (1998) (33)
Pathology of peripheral neuroblastic tumors: Significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma (2008) (32)
Computer-Aided Grading of Neuroblastic Differentiation: Multi-Resolution and Multi-Classifier Approach (2007) (32)
TrkA expression in peripheral neuroblastic tumors (2004) (32)
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis (2017) (32)
Protein-Losing Enteropathy Caused by Gastrointestinal Tract–Involved Langerhans Cell Histiocytosis (2010) (30)
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. (2014) (30)
Enlarged and prominent nucleoli may be indicative of MYCN amplification (2005) (30)
Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways. (2005) (29)
Human osteosarcoma CD49f−CD133+ cells: impaired in osteogenic fate while gain of tumorigenicity (2012) (29)
Screening for neuroblastoma in north america. Preliminary results of a pathology review from the quebec project (1995) (29)
Peripheral neuroblastic tumors with genotype–phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee (2013) (27)
Tumors of the neuroblastoma group (1999) (27)
Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. (2019) (26)
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group (2017) (26)
Computer-aided prognosis of neuroblastoma: classification of stromal development on whole-slide images (2008) (25)
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma (2012) (25)
Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges. (2006) (24)
Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph+ALL04 (2015) (24)
Significance of CD66c expression in childhood acute lymphoblastic leukemia. (2014) (23)
Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging (2019) (23)
Tumoral invasion in the central nervous system (1993) (23)
Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology: A Report from the Children's Oncology Group (2010) (22)
Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ–TIF2 fusion (2013) (22)
Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group (2016) (21)
Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy (2012) (21)
TRANSMISSION AND SCANNING ELECTRON MICROSCOPIC STUDIES ON THE TUMORS OF NEUROBLASTOMA GROUP (1982) (21)
Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors. (2005) (21)
Pelvic neuroblastoma—Implications for a new favorable subgroup: A Children's cancer group experience (1995) (20)
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models. (2020) (20)
Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy (1996) (19)
Transformation of tissue-cultured xeroderma pigmentosum fibroblasts by treatment with N-methyl-N′ -nitro-N-nitrosoguanidine (1976) (19)
Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder. (2011) (19)
TraJ-Dependent Escherichia coli K1 Interactions with Professional Phagocytes Are Important for Early Systemic Dissemination of Infection in the Neonatal Rat (2004) (19)
Utility of Phox2b immunohistochemical stain in neural crest tumours and non‐neural crest tumours in paediatric patients (2018) (19)
Pathology review of screening negative neuroblastomas (1998) (18)
Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression. (2009) (17)
Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts (2016) (17)
Cancer Therapy : Clinical Phase I Study of Vincristine , Irinotecan , and 131 I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma : A New Approaches to Neuroblastoma Therapy Trial (2012) (17)
Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. (2017) (16)
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma (2021) (16)
[Pathology of peripheral neuroblastic tumors]. (2006) (16)
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project. (2012) (15)
Neuroblastoma Pathology and Biology (1992) (14)
Computer-assisted grading of neuroblastic differentiation. (2008) (14)
Neuroblastoma of unknown primary site with periorbital bone metastasis in a child (2010) (14)
Histopathologic features of composite ganglioneuroblastoma. Immunohistochemical distinction of the stromal component is related to prognosis (1990) (13)
Clinical outcomes after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A report from the Japan Society for Hematopoietic Cell Transplantation. (2019) (13)
Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression. (2019) (13)
A Combined Computerized Classification System for Whole-slide Neuroblastoma Histology: Model-based Structural Features (2009) (12)
The clinical management and outcomes of cervical neuroblastic tumors. (2016) (12)
The lost intrinsic fragmentation of MAT1 protein during granulopoiesis promotes the growth and metastasis of leukemic myeloblasts (2013) (12)
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma (2020) (12)
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium (2021) (12)
A feasibility and phase II study of the hu14.18-IL2 immunocytokine in combination with GM-CSF and isotretinoin in patients with recurrent or refractory neuroblastoma: A Children’s Oncology Group study. (2015) (11)
Nonsense mutation in HLA‐B*40:02 in a case with acquired aplastic anaemia: a possible origin of clonal escape from autoimmune insult (2013) (11)
Experimental Parainfluenzavirus Infection (1978) (11)
Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification. (2019) (11)
Sequential use of second‐generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (2018) (11)
Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study (2019) (11)
Rare MYC-amplified Neuroblastoma With Large Cell Histology (2018) (10)
Neuroblastoma in an adult. (2004) (10)
Histologic and ultrastructural features in early and advanced phases of Zellweger spectrum disorder (infantile Refsum disease) (2018) (10)
Colocolic intussusception associated with pneumatosis cystoides intestinalis after cord blood stem cell transplantation. (2004) (10)
Generic formulations of imatinib for treatment of Philadelphia chromosome–positive leukemia in pediatric patients (2018) (10)
Tissue inhibitors of metalloproteinases: role in tumor progression. (1994) (10)
Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia (2018) (9)
A Case of Composite Neuroblastoma Composed of Histologically and Biologically Distinct Clones (2007) (9)
MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival. (2014) (9)
Am80‐GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia‐associated infection and mortality (2016) (9)
Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after a cord blood stem cell transplantation presenting with pulmonary nodules. (2004) (9)
Assessment of NMYC amplification: a comparison of FISH, quantitative PCR monoplexing and traditional blotting methods used with formalin-fixed, paraffin-embedded neuroblastomas. (2005) (9)
Experimental parainfluenzavirus infection. 1. Hydrocephalus of mice due to infection with parainfluenza virus type 1 and type 3. (1978) (9)
Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126 (2016) (9)
Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study). (2019) (8)
A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study (2021) (8)
Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model (2020) (8)
A multi-resolution image analysis system for computer-assisted grading of neuroblastoma differentiation (2008) (8)
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma (2021) (8)
Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model. (2013) (8)
Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group. (2020) (8)
Predictors of response, progression‐free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high‐risk neuroblastoma (2018) (8)
A case of multisystem Langerhans cell histiocytosis with primary hypothyroidism followed by type 1 diabetes mellitus (2009) (8)
In Situ Neuroblastoma: An Important Concept Related to the Natural History of Neural Crest Tumors (2005) (7)
Age, tumor grade, and mitosis-karyorrhexis index (MKI) are independently predictive of outcome in neuroblastoma (NB) (2007) (7)
Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91). (1993) (7)
The establishment of a malignant rhabdoid tumor cell line with a specific chromosomal translocation, t(11p;22q) (1989) (7)
Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway (2013) (7)
Combining inhibitors of Brd4 and cyclin-dependent kinase can decrease tumor growth in neuroblastoma with MYCN amplification. (2021) (6)
Management of Stage 4S Composite Neuroblastoma With a MYCN-amplified Nodule (2014) (6)
The pineal, pituitary, parathyroid, thyroid, and adrenal glands (2012) (6)
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. (2021) (6)
Successful treatment of metastatic rhabdomyosarcoma with radiochemotherapy and allogeneic hematopoietic stem cell transplantation. (2015) (6)
Safety and efficacy of linezolid in 16 infants and children in Japan (2012) (6)
Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report (2012) (6)
A phase III trial of biologically-based therapy reduction for intermediate risk neuroblastoma (2007) (6)
Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children (2014) (6)
Haploidentical stem cell transplantation with posttransplant cyclophosphamide for refractory systemic juvenile xanthogranuloma (2019) (5)
The germline TP53 mutation c.722 C>T promotes bone and liver tumorigenesis at a young age (2012) (5)
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma (2021) (5)
A paradoxical thrombogenic mutation in factor II at the target site of arthropod bleeding toxin. (2019) (5)
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia (2022) (5)
Importance of Phox2B Immunohistochemical Stain for Detecting Metastatic Neuroblastoma Cells in Bone Marrow Specimens (2016) (4)
Adjuvant CD49d Blockade Eradicates Chemoresistant ALL (2010) (4)
Unrelated Bone Marrow Transplantation for Children with Chronic Myeloid Leukemia (CML): A Report from the Japan Marrow Donor Program (JMDP). (2008) (4)
Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group (2022) (4)
Neuroblastoma - Present and Future (2012) (4)
Cytologic and Ultrastructural Findings of Bronchoalveolar Lavage in Patients With Chronic Granulomatous Disease (2018) (4)
Correspondence re: J. Mora et al., Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res., 61: 6892-6898, 2001. (2002) (4)
Generalized eruptive histiocytoma developing into xanthoma disseminatum with central diabetes insipidus (2019) (3)
Hospitalists should have increased suspicion for primary ciliary dyskinesia in patients with congenital heart disease. (2014) (3)
Salvage therapy for children with relapsed or refractory Philadelphia chromosome‐positive acute lymphoblastic leukemia (2017) (3)
Neuroblastoma Pathology and Classification for Precision Prognosis and Therapy Stratification (2019) (3)
Re: Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children. (2012) (3)
A Case of Pulmonary Veno-Occlusive Disease Following Hepatic Veno-Occlusive Disease After Autologous Hematopoietic Stem Cell Transplantation for Neuroblastoma. (2020) (3)
Prognostic markers for stage 3 neuroblastoma (NB): A report from the International Neuroblastoma Risk Group (INRG) project (2008) (3)
Pharmacokinetics, Efficacy and Safety of Bosutinib in a Pediatric Patient With Chronic Myeloid Leukemia. (2020) (3)
Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation (2017) (3)
Outcome of high risk (HR) stage 3 neuroblastoma (NB) with myeloablative therapy and 13-cis-retinoic Acid (2005) (3)
Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma. (2020) (3)
Primary renal neuroblastoma. (2012) (2)
Large congenital melanocytic nevi with atypical teratoid/rhabdoid tumor (2013) (2)
Activity of fenretinide/Lym-X-Sorb oral powder combined with the oral microtubule inhibitor ABT-751 against multidrug-resistant neuroblastoma xenografts (2008) (2)
Stage 4S Neuroblastoma (2020) (2)
Phase II study of alisertib, irinotecan, and temozolomide in children with relapsed and refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy (NANT) consortium. (2016) (2)
Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion (2020) (2)
Growth‐chart‐based qualitative evaluation of height growth after hematopoietic stem cell transplantation (2006) (2)
Clinical Implications of Neuroblastoma Stem Cells (2013) (2)
MIBG) for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) Trial (2012) (2)
Genetic and Histopathological Heterogeneity of Neuroblastoma and Precision Therapeutic Approaches for Extremely Unfavorable Histology Subgroups (2022) (2)
A case of primary CNS embryonal rhabdomyosarcoma with PAX3-NCOA2 fusion and systematic meta-review (2021) (2)
Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium. (2020) (2)
Forearm Skeletal Muscle Neuroblastoma in a Child: A Rare Primary Location (2013) (2)
CONVENTIONAL VERSUS SPECIAL NEUROBLASTOMA (NB): FAVORABLE PROGNOSIS CORRELATES WITH STROMAL DIFFERENTIATION (1987) (1)
A Brief Use of Imatinib Immediately Before Hematopoietic Stem Cell Transplantation (HSCT) in Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL). Results of the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph+ALL04 (2011) (1)
Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome (2017) (1)
Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic‐phase chronic myeloid leukemia treated with imatinib (2017) (1)
Plasminogen Activator Inhibitor-1 Promotes Angiogenesis by Stimulating Endothelial Cell Migration toward Fibronectin 1 (2001) (1)
Neuroblastoma and Related Tumors (2005) (1)
Prognostic Signi fi cance of Gene Expression Pro fi les of Metastatic Neuroblastomas Lacking MYCN Gene Ampli fi cation (1)
Pioneer in Pediatric Pathology: William A (Bill) Newton Jr (1923–) (2018) (1)
' s response to reviews Title : Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer : Increased expression of a CD 44 variant isoform after chemotherapy (2012) (1)
Cervical Edema Extending to the Larynx as Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-Cell Therapy in a Boy with Refractory Acute Lymphoblastic Leukemia (2022) (1)
Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults with CML in the TKI Era. (2022) (1)
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group (2022) (1)
Reduced-Intensity Allogeneic HSCT for Children and Adolescents/Young Adults with CML: A Study from the Adult and Pediatric CML Working Group of the Japan Society for Hematopoietic Cell Transplantation (2018) (1)
[Prevalence of the antibody against human polyoma viruses (JCV and BKV) in aged persons]. (1990) (1)
and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study (2015) (1)
Two cases of neuroblastoma comprising two distinct clones (2014) (1)
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma (2022) (1)
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. (2023) (1)
Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma (2015) (1)
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia (2010) (1)
The contribution of bone marrow mesenchymal stem cells in the bone metastasis of neuroblastoma (2004) (1)
A pilot induction regimen incorporating dinutuximab and sargramostim for the treatment of newly diagnosed high-risk neuroblastoma: A report from the Children's Oncology Group. (2022) (1)
An unusual case of neuroblastoma with angiomatoid features. (2007) (1)
PF412 A PHASE 2 STUDY OF NILOTINIB (NIL) IN PEDIATRIC PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME–POSITIVE CHRONIC MYELOID LEUKEMIA (CML): SAFETY UPDATE AFTER 36 CYCLES OF TREATMENT (2019) (1)
Replicating and identifying large cell neuroblastoma using high-dose intra-tumoral chemotherapy and automated digital analysis. (2019) (1)
Large cell neuroblastoma – Phenotypical variant of MYC-driven neuroblastoma: Report of 2 cases with different molecular characteristics (2021) (1)
Rationale and Design of a Prospective, Multicentre, Stop Tyrosine Kinase Inhibitor Trial of Paediatric Patients with Chronic Myeloid Leukaemia with Sustained Complete Molecular Response (STKI-14) (2018) (1)
Title Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia : Results from Japanese Pediatric Leukemia / Lymphoma Study Group ( JPLSG ) Study Ph + ALL 04 (2018) (1)
Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors. (2020) (1)
696. Comparative study of lentiviral vector-mediated gene therapy in neonatal and young-adult MPS I mice by a single intravenous injection (2004) (0)
Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032. (2020) (0)
Abstract 2497: Inhibitors of RNA Pol I and an aminoacyl-tRNA synthetase result in MYC and MYCN downregulation in MYC family protein-driven neuroblastoma cells (2018) (0)
Prognostic significance of genomic alterations of metastatic neuroblastomas. (2007) (0)
P116: Six cases of cervical pregnancy and a literature review (2003) (0)
Biologic V ariables i n t he O utcome o f S tages I a nd I I Neuroblastoma T reated W ith S urgery a s P rimary T herapy: A C hildren's C ancer G roup S tudy (2000) (0)
An Infant With Neuroblastoma and MYCN Amplification Found Through Mass Screening (1998) (0)
Abstract 400: MEK inhibition enhances immune checkpoint blockade treatment of murine models of neuroblastoma (2015) (0)
Testicular involvement without testicular enlargement in a young male with atypical chronic myeloid leukemia (2019) (0)
Does MYCN AmplificationManifested as Homogeneously Staining Regions at Diagnosis Predict aWorse Outcome in Childrenwith Neuroblastoma ? AChildren ’ s Oncology Group Study (2006) (0)
Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy (2012) (0)
12. Pediatric oncology testing in the front-line setting: Utility of the CHLA OncoKids panel (2018) (0)
P2.03-032 Efficacy and Safety of Osimertinib as Third-Line or Later Therapy for T790M-Positive Advanced Non-Small Cell Lung Cancer (2017) (0)
Langerhans Cell Histiocytosis Involved − Protein-Losing Enteropathy Caused by Gastrointestinal Tract (2010) (0)
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Retinoid agonistAm80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model (2017) (0)
Glioma and Medulloblastoma Growth Inhibition by αV Integrin Antagonist (1999) (0)
Undifferentiated Neuroblastoma : Extremely Rare and Unfavorable Subtype of Neuroblastoma (2001) (0)
Composite Neuroblastoma Metastatic to a Lymph Node: The Novel Histopathologic Diagnosis of a Unique Multiclonal Neoplasm. (2021) (0)
Photodynamic Therapy ( PDT ) with Hematoporphyrin Derivative ( HpD ) for Atherosclerotic , Lesions in Rabbits — Dosage , Administration route of HpD and Effectiveness of a New Fiber for (2012) (0)
Abstract 2654: Induced stable neuroblastoma stem cells recapitulate in vivo highly aggressive large-cell neuroblastomas. (2013) (0)
Spontaneous Alleviation Of Growth Impairment In Tyrosine Kinase Inhibitor-Treated Chronic Myeloid Leukemia Children (2013) (0)
P3.16.24 Management of endodermal sinus tumors of ovary with alphafetoprotein (2000) (0)
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (2019) (0)
Abstract A37: Immunohistochemical detection of MYCN protein and MYC protein identifies highly aggressive neuroblastomas (2015) (0)
Neuroblastoma and Neuroblastic Tumors (2018) (0)
Abstract 508: Signal transduction and activator of transcription (STAT) 3 is necessary for environment-mediated drug resistance (2011) (0)
Neuroblastoma pathology: An update (2017) (0)
A unique composite tumour of the adrenal gland in a paediatric patient, with adrenal cortical and neural crest cell-like components. (2021) (0)
Reprogramming the neuroblastoma epigenome with a mitochondrial uncoupler (2021) (0)
Anti-tumoral and anti-osteolytic activity of zoledronic acid (ZA) in a preclinical model of neuroblastoma bone invasion (2006) (0)
Interim Analysis of a Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study (2015) (0)
24IL1 Pathology of Pediatric Solid Tumors (2006) (0)
Fanconi syndrome secondary to deferasirox with severe and prolonged urinary potassium loss in a β-thalassemia major patient (2021) (0)
Pathology of Pediatric Solid Tumors (2006) (0)
Recent progress in the management of pediatric chronic myeloid leukemia (2022) (0)
Severe bloody diarrhea due to cytokine release syndrome after chimeric antigen receptor T cell therapy for refractory acute lymphoblastic leukemia (2021) (0)
Papovavirus detection by electron microscopy in the brain of an elderly patient without overt progressive multifocal leukoencephalopathy (2004) (0)
Severe hypertriglyceridemia during treatment of acute lymphoblastic leukemia associated with type III hyperlipoproteinemia (2017) (0)
Erratum (2018) (0)
Neuroblastoma : Role of PA Inhibitor-1 in Metastasis The Plasminogen-Plasminogen Activator ( PA ) System in Updated Version (1999) (0)
A Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study (2021) (0)
EP1.09-02 Expression of Intratumoral GFPT2 in Lung Adenocarcinoma (2019) (0)
A Case of Childhood Blastic Phase Chronic Myeloid Leukemia With Minor BCR-ABL. (2020) (0)
A Case of Invasive Fungal Rhinosinusitis Accompanied by Transplantation Therapy for JMML (2005) (0)
Pediatric Granular Cell Tumors: Clinicopathologic and Molecular Analysis of Six Cases Including Multicentric, Atypical, Malignant, and Non-Neural Tumors (2020) (0)
IS O-06 Interleukin-6 Promotes Proliferation and Survival of Neuroblastoma cells in the Bone Marrow Microenvironment(International Session 2 Tumor,Science and Art for Sick Children) (2009) (0)
Gene Expression Signature in Human Neuroblastoma with TERT Overexpression Can Be Identified by Gene Set Enrichment Analysis and Epigenetically Targeted in an Orthotopic Mouse Xenograft Model (2020) (0)
Human Cancer Biology Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology : A Report from the Children ' s Oncology Group (2010) (0)
P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer (2018) (0)
[Treatment strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia in children]. (2022) (0)
Biologic F actors D etermine P rognosis i n I nfants W ith Stage I V N euroblastoma: A P rospective C hildren's C ancer Group S tudy (2000) (0)
Abstract 383: Interleukin-6 producing tumor associated macrophages (TAMs) increase MYC expression and promote tumor growth in a novel murine neuroblastoma model (2012) (0)
Extrarenal malignant rhabdoid tumors: Phenotypical and cytogenetic study (1991) (0)
Abstract A182: PI3K inhibitors overcome resistance to HER2‐targeted agents caused by PIK3CA mutations in HER2‐amplified breast cancer cell lines (2009) (0)
Abstract 3668: Tumor-associated macrophages (TAMs) promote murine neuroblastoma tumor growth through upregulation of MYC and independent of IL6 expression (2014) (0)
P1.03-010 Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer (2017) (0)
High‐dose chemotherapy without whole lung radiation for refractory pulmonary metastases in an infant with stage IV favorable histology Wilms tumor (2018) (0)
Abstract 557: Galectin-3 binding protein produced by neuroblastoma cells stimulates the expression of interleukin-6 in bone marrow mesenchymal cells (2010) (0)
Outcome analysis of non-high-risk neuroblastoma patients enrolled on Children’s Oncology Group trials P9641 and A3961. (2012) (0)
P2.11-12 Metabolomic Analysis in Lung Cancer for Screening and Early Detection (2018) (0)
The Role of the Clinical Laboratory in the Diagnosis of Neuroblastoma. (2020) (0)
, Ignacio within Human and Rat Macrophages Neonatal Rat : Survival and Replication Brain Abscess in the Citrobacter koseri (2003) (0)
Abstract B40: MYCN/MYC protein expression in high-MKI (Mitosis-Karyorrhexis Index) neuroblastomas: A report from the Children's Oncology Group (2014) (0)
Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma. (2012) (0)
Optimizing Sustained Release Local Therapy: Single vs Dual Chemotherapy for the Treatment of Neuroblastoma (2019) (0)
Time to resolution of iodine‐123 metaiodobenzylguanidine (123I‐MIBG) avidity and local control outcomes for high‐risk neuroblastoma following radiation therapy (2022) (0)
Effect of insulin-like growth factor 2 gene expression on pleuropulmonary blastoma and embryonal rhabdomyosarcoma. (2012) (0)
RESIDUAL MASS DISEASE IN INTERMEDIATE RISK STAGE 4 NEUROBLASTOMA: USING HISTOPATHOLOGY TO ASSESS OUTCOME AND FURTHER TREATMENT (2009) (0)
Electron microscopic findings in a case of fatal human measles pneumonia (1997) (0)
Abstract 3963: MYCN-dependent expression of sulfatase2 regulates neuroblastoma cell survival (2014) (0)
P2.01-051 Myeloid-Derived Suppressor Cell Expression within the Microenvironment of Lung Adenocarcinoma: Topic: Immune Mechanisms in Thoracic Cancer and Targeted Therapy (2017) (0)
The histopathology of the liver in older patients with hepatitis B virus surface antigenaemia (2005) (0)
Chemotherapy with the Use of TKIs Based on MRD Has the Potential to Avoid Hematopoietic Stem Cell Transplantation in Treatment for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL). Results of the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study ALL-P (2021) (0)
GCT-47. TREATMENT STRATEGIES FOR GIANT IMMATURE TERATOMAS IN INFANTS (2020) (0)
The Role of Surgery in Localized Neuroblastoma (1986) (0)
外周神经母细胞性肿瘤临床病理特点 (2012) (0)
Neuroblastoma or not neuroblastoma. (2014) (0)
Abstract 5076: Tumor cell-derived exosomes educate bone marrow mesenchymal stromal cells toward a protumorigenic function (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hiroyuki Shimada?

Hiroyuki Shimada is affiliated with the following schools:

Hiroyuki Shimada's Academic­Influence.com Rankings

Hiroyuki Shimada's Degrees

Similar Degrees You Can Earn

Why Is Hiroyuki Shimada Influential?

Hiroyuki Shimada's Published Works

Published Works

What Schools Are Affiliated With Hiroyuki Shimada?

Hiroyuki Shimada's AcademicInfluence.com Rankings